| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 12/15/2010 | CN101194981B Powder medicament for treating otitis media chronica |
| 12/15/2010 | CN101006999B Therapeutic uses and compositions of isoflavones |
| 12/14/2010 | US7851586 Peptides for activation and inhibition of δPKC |
| 12/14/2010 | US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 12/14/2010 | US7850993 Drug-releasing system of biodegradable polymer type |
| 12/14/2010 | US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders |
| 12/14/2010 | US7850963 Vascular endothelial growth factor 2 |
| 12/14/2010 | CA2470044C Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 12/14/2010 | CA2366857C Phthalazine derivatives for treating inflammatory diseases |
| 12/14/2010 | CA2355939C Antihistaminic spiro compounds |
| 12/09/2010 | WO2010141586A2 Therapeutic ophthalmic emulsions |
| 12/09/2010 | WO2010141427A1 Treatment of ophthalmologic disorders mediated by albha-carbonic anhydrase isoforms |
| 12/09/2010 | WO2010140698A1 Method for induction of differentiation of neural crest cells from pluripotent stem cells |
| 12/09/2010 | WO2010139954A1 Treatment of eye discomfort by topical administration of a cooling agent to the external surface of the eyelid |
| 12/09/2010 | WO2010139678A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 12/09/2010 | US20100311840 Oral formulations of bis(thiohydrazide amides) |
| 12/09/2010 | US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 12/09/2010 | US20100311808 METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES |
| 12/09/2010 | US20100311778 Chromane derivatives as trpv3 modulators |
| 12/09/2010 | US20100311720 Spiroindoline Modulators of Muscarinic Receptors |
| 12/09/2010 | US20100311716 Use of inhibitors of jun n-terminal kinases to treat glaucoma |
| 12/09/2010 | US20100311705 Ophthalmologic irrigation solutions and method |
| 12/09/2010 | US20100311688 Ophthalmic formulations, methods of manufacture, and methods of using same |
| 12/09/2010 | US20100310651 Solid pharmaceutical compositions and processes for their production |
| 12/09/2010 | US20100310642 Topical Drug Delivery Systems for Ophthalmic Use |
| 12/09/2010 | US20100310637 Composition and method for the treatment or prevention of glaucoma and ocular hypertension |
| 12/09/2010 | US20100310630 Coated surface for cell culture |
| 12/09/2010 | US20100310622 Dry eye treatment by puncta plugs |
| 12/09/2010 | US20100310585 The use of monomycolyl glycerol (mmg) as an adjuvant |
| 12/09/2010 | US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae |
| 12/09/2010 | US20100310555 Compositions with hematopoietic and immune activity |
| 12/09/2010 | US20100310549 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 12/09/2010 | US20100310465 Nano-devices having releasable seals for controlled release of molecules |
| 12/09/2010 | CA2764802A1 Artificial tears and therapeutic uses |
| 12/09/2010 | CA2764477A1 Ophthalmic formulations, methods of manufacture, and methods of using same |
| 12/09/2010 | CA2764326A1 Therapeutic ophthalmic emulsions |
| 12/08/2010 | EP2258834A1 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |
| 12/08/2010 | EP2258687A1 Nicotinamide derivates useful as P38 inhibitors |
| 12/08/2010 | EP2258365A1 Use of organic compounds for immunopotentiation |
| 12/08/2010 | EP2258363A1 Compositions for treatment of cancers |
| 12/08/2010 | EP2257569A1 Method of treatment using antimicrobial composition |
| 12/08/2010 | EP2257296A1 Poly aromatic sodium channel blockers |
| 12/08/2010 | EP1884237B1 Amidino derivatives for use in the prevention or treatment of glaucoma |
| 12/08/2010 | EP1679074B1 Therapeutic agent for keratoconjunctive disorder |
| 12/08/2010 | EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 12/08/2010 | EP1471926B1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 12/08/2010 | EP1383487B1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 12/08/2010 | EP1321144B1 Eye drops |
| 12/08/2010 | CN1939506B Preparation with blood-pressure, blood-sugar and blood-fat lowering functions and its making method |
| 12/08/2010 | CN1864688B Agent for preventing and treating glaucoma |
| 12/08/2010 | CN1824061B Application of a combination for preparing medicine and food dual purpose nutrient for preventing true myopia |
| 12/08/2010 | CN1671696B Kinase inhibitors |
| 12/08/2010 | CN1650005B Antimicrobial polypeptide and utizliation thereof |
| 12/08/2010 | CN101910160A Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 12/08/2010 | CN101906071A Dioxane-2-alkyl carbamates derivatives |
| 12/08/2010 | CN101904978A Decoction medicament for treating auditory vertigo |
| 12/08/2010 | CN101904947A Fructus viticis extract and supercritical preparation process thereof |
| 12/08/2010 | CN101904889A Method for identifying isatis root in Chinese medicinal preparations |
| 12/08/2010 | CN101904841A Phenylphthalimide analog and its application for preparing diabetic macular edema drugs |
| 12/08/2010 | CN101904819A Method for preparing taurine particles |
| 12/08/2010 | CN101642511B Traditional Chinese medicine composition for relieving visual fatigue and treating pseudomyopia and preparation method thereof |
| 12/08/2010 | CN101433711B Chinese medicinal composition for treating deafness |
| 12/08/2010 | CN101371828B Hypocrellin liposome preparation and preparation method thereof |
| 12/08/2010 | CN101210050B Antibodies for preventing bloodvessel endothelium growth factor |
| 12/07/2010 | US7846468 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/07/2010 | US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection |
| 12/07/2010 | US7845348 Methods for treating trigeminal neuralgia |
| 12/07/2010 | US7845347 Methods for treating headaches |
| 12/07/2010 | CA2456029C Stable emulsion composition |
| 12/07/2010 | CA2256543C Methods and compositions useful for inhibition of angiogenesis |
| 12/02/2010 | WO2010138210A1 Methods of saponifying xanthophyll esters and isolating xanthophylls |
| 12/02/2010 | WO2010137681A1 Prophylactic or therapeutic agent for retinal diseases comprising tranilast, method for prevention or treatment of retinal diseases, and tranilast or pharmaceutically acceptable salt thereof and use thereof |
| 12/02/2010 | WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors |
| 12/02/2010 | WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors |
| 12/02/2010 | WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME |
| 12/02/2010 | WO2010136492A2 Antigen-binding proteins |
| 12/02/2010 | WO2010109212A3 Carrier comprising a vitamin e derivative |
| 12/02/2010 | WO2010057028A3 Treatment of proteinopathies using a farnesyl transferase inhibitor |
| 12/02/2010 | WO2009120699A3 Antimicrobials having polyquarternary ammoniums and alcohol-bearing amidoamines and methods for their use |
| 12/02/2010 | US20100305200 Compounds that modulate intracellular calcium |
| 12/02/2010 | US20100305193 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 12/02/2010 | US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna |
| 12/02/2010 | US20100305189 Pharmaceutical composition for preventing, stabilising and/or inhibiting blood and lymph vascularization |
| 12/02/2010 | US20100305177 Prophylactic or therapeutic agent for diabetic maculopathy |
| 12/02/2010 | US20100305175 Pharmaceutical latrunculin formulations |
| 12/02/2010 | US20100305162 Methods for the Synthesis of Pyridoxamine |
| 12/02/2010 | US20100305131 Substituted Aminopropionic Derivatives as Neprilysin inhibitors |
| 12/02/2010 | US20100305104 Oxadiazole Diaryl Compounds |
| 12/02/2010 | US20100305093 Inhibitors of mTOR and Methods of Making and Using |
| 12/02/2010 | US20100305075 Composition and method of treating hearing loss |
| 12/02/2010 | US20100305066 Fused Thiophene Derivatives as Kinase Inhibitors |
| 12/02/2010 | US20100305046 Stable cyclosporine containing ophthalmic emulsion for treating dry eyes |
| 12/02/2010 | US20100305037 Cyclosporin derivatives for treating inflammatory diseases and conditions |
| 12/02/2010 | US20100305034 Growth factor isoform |
| 12/02/2010 | US20100303926 Organic compounds |
| 12/02/2010 | US20100303915 Therapeutic opthalmic emulsions |
| 12/02/2010 | US20100303890 Copolymers suitable for use in corneal bandages |
| 12/02/2010 | US20100303887 DHA and PEDF, a Therapeutic Composition for Nerve and Retinal Pigment Epithelial Cells |
| 12/02/2010 | US20100303871 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |